Citigroup’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$304K Sell
15,280
-14,452
-49% -$287K ﹤0.01% 3162
2025
Q1
$502K Sell
29,732
-6,735
-18% -$114K ﹤0.01% 2944
2024
Q4
$674K Buy
36,467
+3,375
+10% +$62.3K ﹤0.01% 2833
2024
Q3
$719K Buy
33,092
+10,236
+45% +$222K ﹤0.01% 2777
2024
Q2
$448K Buy
22,856
+2,173
+11% +$42.6K ﹤0.01% 2768
2024
Q1
$449K Buy
20,683
+6,406
+45% +$139K ﹤0.01% 2925
2023
Q4
$413K Buy
14,277
+4,739
+50% +$137K ﹤0.01% 2824
2023
Q3
$255K Sell
9,538
-6,418
-40% -$172K ﹤0.01% 2854
2023
Q2
$591K Buy
15,956
+5,103
+47% +$189K ﹤0.01% 2622
2023
Q1
$339K Sell
10,853
-4,856
-31% -$152K ﹤0.01% 2805
2022
Q4
$468K Buy
15,709
+4,847
+45% +$144K ﹤0.01% 2580
2022
Q3
$414K Buy
10,862
+610
+6% +$23.3K ﹤0.01% 2710
2022
Q2
$559K Sell
10,252
-9,900
-49% -$540K ﹤0.01% 2513
2022
Q1
$1.26M Buy
20,152
+702
+4% +$43.8K ﹤0.01% 2135
2021
Q4
$1.96M Buy
19,450
+606
+3% +$60.9K ﹤0.01% 1988
2021
Q3
$1.7M Buy
18,844
+366
+2% +$32.9K ﹤0.01% 2030
2021
Q2
$1.7M Buy
18,478
+16,960
+1,117% +$1.56M ﹤0.01% 2204
2021
Q1
$147K Sell
1,518
-1,774
-54% -$172K ﹤0.01% 3532
2020
Q4
$172K Buy
3,292
+2,827
+608% +$148K ﹤0.01% 3320
2020
Q3
$19K Sell
465
-872
-65% -$35.6K ﹤0.01% 3988
2020
Q2
$21K Sell
1,337
-523
-28% -$8.22K ﹤0.01% 4212
2020
Q1
$20K Buy
1,860
+912
+96% +$9.81K ﹤0.01% 4359
2019
Q4
$12K Buy
+948
New +$12K ﹤0.01% 4658
2017
Q2
Sell
-171
Closed -$2K 4896
2017
Q1
$2K Sell
171
-22,709
-99% -$266K ﹤0.01% 4636
2016
Q4
$265K Buy
+22,880
New +$265K ﹤0.01% 3404